GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Edgewise Therapeutics, Inc. - Common Stock, $0.0001 par value per share (EWTX)

Symbol: EWTX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$43,340,399	1,746,222	+28,581	+1.7%	$24.82	Q4 2025
30 Sep 2025	0%	-0%	$27,864,280	1,717,641	-79,574	-4.4%	$16.22	Q3 2025
30 Jun 2025	0%	+0%	$23,564,445	1,797,215	+141,551	+8.5%	$13.11	Q2 2025
31 Mar 2025	0%	+0%	$36,431,749	1,655,664	+55,093		$22.00	Q1 2025
31 Dec 2024	0%	+0%	$42,743,958	1,600,571	+1,036	+0.06%	$26.71	Q4 2024
30 Sep 2024	0%	-0%	$42,698,606	1,599,535	-73,118	-4.4%	$26.69	Q3 2024
30 Jun 2024	0%	+0%	$30,130,154	1,672,653	+302,756	+22%	$18.01	Q2 2024
31 Mar 2024	0%	+0%	$24,991,047	1,369,897	+422,851	+45%	$18.24	Q1 2024
31 Dec 2023	0%	+0%	$10,361,767	947,046	+55,278	+6.2%	$10.94	Q4 2023
30 Sep 2023	0%	+0%	$5,110,456	891,768	+35,556	+4.2%	$5.73	Q3 2023
30 Jun 2023	0%	+0%	$6,635,643	856,212	+80,725	+10%	$7.75	Q2 2023
31 Mar 2023	0%	+0%	$5,172,498	775,487	+53,342	+7.4%	$6.67	Q1 2023
31 Dec 2022	0%	+0%	$6,455,000	722,145	+198,624	+38%	$8.94	Q4 2022
30 Sep 2022	0%	+0%	$5,151,000	523,521	+126,691	+32%	$9.84	Q3 2022
30 Jun 2022	0%	-0%	$3,158,000	396,830	-41,311	-9.4%	$7.96	Q2 2022
31 Mar 2022	0%	+0%	$4,249,000	438,141	+46,559	+12%	$9.70	Q1 2022
31 Dec 2021	0%	+0%	$5,983,000	391,582	+148,663	+61%	$15.28	Q4 2021
30 Sep 2021	0%	+0%	$4,032,000	242,919	+497	+0.21%	$16.60	Q3 2021
30 Jun 2021	0%	+0%	$5,170,000	242,422	+242,422	NEW	$21.33	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.